MEDIUMResearchTier 1
Why does dentine hypersensitivity remain undertreated despite being common and manageable?
SourceJournal of DentistryTier 1Peer-Reviewed Research
Originally at sciencedirect.com
Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.
Why it matters for dental
Practice owners and clinicians in Australia face ongoing revenue leakage and patient dissatisfaction because dentine hypersensitivity remains systematically undertreated despite available, evidence-based therapies; the study quantifies patient-level and system-level barriers that suppress case acceptance.
Key points
- Australian general dentists report hypersensitivity as a high-prevalence condition yet rank it low on treatment priority, leading to missed billable procedures.
- Patient interviews reveal cost, fear of invasive treatment, and lack of insurance coverage as primary reasons for declining recommended desensitizing agents or restorative options.
- System barriers identified include absence of specific Medicare item numbers for hypersensitivity management and limited chair-side time allocated for diagnosis.
- Authors recommend targeted fee-structure reform and chair-side screening protocols to convert undertreated cases into scheduled procedures.
Who should care
OwnerAssociateAcademia
Read the original on Journal of Dentistry
Full reporting and any paywall content live on sciencedirect.com. We summarize and score; we do not republish.